Advertisement
UK markets closed
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • CRUDE OIL

    79.38
    +0.39 (+0.49%)
     
  • GOLD FUTURES

    2,340.30
    +18.00 (+0.78%)
     
  • DOW

    39,242.21
    +185.82 (+0.48%)
     
  • Bitcoin GBP

    49,861.84
    +83.86 (+0.17%)
     
  • CMC Crypto 200

    1,345.68
    +45.58 (+3.51%)
     
  • NASDAQ Composite

    16,336.03
    +33.27 (+0.20%)
     
  • UK FTSE All Share

    4,558.37
    +14.13 (+0.31%)
     

Why Shares of Amyris Are Getting Crushed Today

Why Shares of Amyris Are Getting Crushed Today

Failing to deliver on both the top and bottom lines, synthetic-biology specialist Amyris (NASDAQ: AMRS) reported disappointing third-quarter 2021 earnings results yesterday after the market closed. In addition, investors are selling shares after learning that the company is raising capital through the issuance of senior convertible notes. Although the company reported a year-over-year sales increase of 39.7%, it didn't seem to be enough to satisfy investors' appetites.